185. Int J Mol Sci. 2018 Feb 21;19(2). pii: E617. doi: 10.3390/ijms19020617.A Metabolomic Approach to Predict Breast Cancer Behavior and ChemotherapyResponse.Cardoso MR(1), Santos JC(2), Ribeiro ML(3), Talarico MCR(4), Viana LR(5),Derchain SFM(6).Author information: (1)Hospital da Mulher Prof. Dr. José Aristodemo Pinotti-Centro de AtençãoIntegral à Saúde da Mulher (CAISM), University of Campinas (UNICAMP), Campinas,São Paulo 13083-881, Brazil. macardoso86@hotmail.com.(2)Hospital da Mulher Prof. Dr. José Aristodemo Pinotti-Centro de AtençãoIntegral à Saúde da Mulher (CAISM), University of Campinas (UNICAMP), Campinas,São Paulo 13083-881, Brazil. santos.j.c@outlook.com.(3)Clinical Pharmacology and Gastroenterology Unit, São Francisco University,Bragança Paulista, São Paulo 13083-881, Brazil. marcelo.ribeiro@usf.edu.br.(4)Hospital da Mulher Prof. Dr. José Aristodemo Pinotti-Centro de AtençãoIntegral à Saúde da Mulher (CAISM), University of Campinas (UNICAMP), Campinas,São Paulo 13083-881, Brazil. mcecilia_r@hotmail.com.(5)Hospital da Mulher Prof. Dr. José Aristodemo Pinotti-Centro de AtençãoIntegral à Saúde da Mulher (CAISM), University of Campinas (UNICAMP), Campinas,São Paulo 13083-881, Brazil. lala.viana311088@gmail.com.(6)Hospital da Mulher Prof. Dr. José Aristodemo Pinotti-Centro de AtençãoIntegral à Saúde da Mulher (CAISM), University of Campinas (UNICAMP), Campinas,São Paulo 13083-881, Brazil. sophie.derchain@gmail.com.Although the classification of breast carcinomas into molecular orimmunohistochemical subtypes has contributed to a better categorization of women into different therapeutic regimens, breast cancer nevertheless still progresses or recurs in a remarkable number of patients. Identifying women who would benefitfrom chemotherapy could potentially increase treatment effectiveness, which hasimportant implications for long-term survival. Metabolomic analyses of fluids andtissues from cancer patients improve our knowledge of the reprogramming ofmetabolic pathways involved in resistance to chemotherapy. This review evaluates how recent metabolomic approaches have contributed to understanding therelationship between breast cancer and the acquisition of resistance. We focus onthe advantages and challenges of cancer treatment and the use of new strategiesin clinical care, which helps us comprehend drug resistance and predict responsesto treatment.DOI: 10.3390/ijms19020617 PMCID: PMC5855839PMID: 29466297 